Filter Results:
(5,435)
Show Results For
- All HBS Web
(5,435)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,953)
Show Results For
- All HBS Web
(5,435)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,953)
- 04 May 2016
- News
Every Company Is a Health Company
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- 21 Oct 2009
- News
Redefining Health Care: Elizabeth Teisberg Interviewed
- October 5, 2017
- Article
Making Patients and Doctors Happier—The Potential of Patient-Reported Outcomes
By: Lisa Rotenstein, Robert S. Huckman and Neil Wagle
Rotenstein, Lisa, Robert S. Huckman, and Neil Wagle. "Making Patients and Doctors Happier—The Potential of Patient-Reported Outcomes." New England Journal of Medicine 377, no. 14 (October 5, 2017): 1309–1312.
- Article
Consumer-Driven Health Care: Freeing Providers to Innovate
Herzlinger, Regina E. "Consumer-Driven Health Care: Freeing Providers to Innovate." hfm (Healthcare Financial Management) 58, no. 3 (March 2004): 66–68.
- May 2016
- Case
AbbVie
By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
- 2021
- Working Paper
The Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes
By: Arlen Guarin, Christian Posso, Estefania Saravia and Jorge Tamayo
Identifying the effect of physicians’ skills on health outcomes is a challenging task due to the nonrandom sorting between physicians and hospitals. We overcome this challenge by exploiting a Colombian government program that randomly assigned 2,126 physicians to 618... View Details
Keywords: Physicians' Health Skills; Health Birth Outcomes; Birthing Outcomes; Experimental Evidence; Health Care and Treatment; Competency and Skills; Outcome or Result; Health Industry; Colombia
Guarin, Arlen, Christian Posso, Estefania Saravia, and Jorge Tamayo. "The Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes." Harvard Business School Working Paper, No. 22-015, February 2021. (R&R American Economic Journal.)
- September 2014 (Revised February 2015)
- Case
Pfizer and AstraZeneca: Marketing an Acquisition (A)
By: John A. Quelch and James Weber
In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to... View Details
Keywords: Health Care Policy; Mergers And Acquisitions; Marketing; Government Relations; Crisis Management; Decision Making; Growth and Development; Management; Markets; Strategy; Pharmaceutical Industry; United Kingdom; United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (A)." Harvard Business School Case 515-007, September 2014. (Revised February 2015.)
- Article
The Inpatient Discharge Lounge as a Potential Mechanism to Mitigate Emergency Department Boarding and Crowding
By: Brian Franklin, Sharif Vakili, Robert S. Huckman, Sarah Hosein, Nicholas Falk, Katherine Cheng, Maria Murray, Sheila Harris, Charles A. Morris and Eric Goralnick
Delayed access to inpatient beds for admitted patients contributes significantly to emergency department (ED) boarding and crowding, which have been associated with deleterious patient safety effects. To expedite inpatient bed availability, some hospitals have... View Details
Keywords: Health Care Delivery; Emergency Room; Operations Improvement; Operations Management; Health Care and Treatment; Service Delivery; Operations; Management; Performance Improvement; Service Operations
Franklin, Brian, Sharif Vakili, Robert S. Huckman, Sarah Hosein, Nicholas Falk, Katherine Cheng, Maria Murray, Sheila Harris, Charles A. Morris, and Eric Goralnick. "The Inpatient Discharge Lounge as a Potential Mechanism to Mitigate Emergency Department Boarding and Crowding." Annals of Emergency Medicine 75, no. 6 (June 2020): 704–714.
- October 2017
- Article
Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data
By: A Jay Holmgren, Vaishali Patel and Julia Adler-Milstein
Achieving an interoperable health care system remains a top US policy priority. Despite substantial efforts to encourage interoperability, the first set of national data in 2014 suggested that hospitals’ engagement levels were low. With 2015 data now available, we... View Details
Keywords: Health; Technology; Electronic Health Records; Health Care and Treatment; Data and Data Sets; Technology Networks; Policy; United States
Holmgren, A Jay, Vaishali Patel, and Julia Adler-Milstein. "Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data." Health Affairs 36, no. 10 (October 2017): 1820–1827.
- 18 Oct 2016
- News
Why Business Should Invest in Community Health
- 01 Dec 2011
- News
Research With Impact: Changing Global Health Practices
public policy, and social challenges. In health care, for example, the dominant policy model assumes that access and affordability are the keys to improving care for the poor. In Ashraf’s view, “We can’t... View Details
- March 2019 (Revised June 2021)
- Case
HelloSelf: Foundation
By: John R. Wells and Benjamin Weinstock
On January 6, 2019, HelloSelf, a London-based “BrainTech” company, founded a year earlier by Charles Wells, soft launched. The proposition was simply to help its members “Be your Best Self.” The company provided its registered members with access to a clinical... View Details
Keywords: Startup; Start-up; Startup Management; Startup Marketing; Startups; Start-ups; BrainTech; Marketing Research; Strategic Decision Making; Strategy Development; Strategy Dynamics; Neuroscience; Cognition; Cognitive Psychology; Health ＆ Wellness; Health Care; Health Care Reform; Health Care Outcomes; Self-awareness; Mental Health; Wellbeing; Wellness; Funding; Equity Financing; Raising Capital; Synergies; Team Building; National Health Insurance; Artificial Intelligence; MVP; Business Startups; Health; Health Care and Treatment; Management; Well-being; Marketing Channels; Decision Making; Strategy; Technology; United Kingdom; London
Wells, John R., and Benjamin Weinstock. "HelloSelf: Foundation." Harvard Business School Case 719-492, March 2019. (Revised June 2021.)
- January 1978
- Case
Zero-Base Budgeting in the Public Health Service
Herzlinger, Regina E. "Zero-Base Budgeting in the Public Health Service." Harvard Business School Case 178-080, January 1978.
- Web
Health Business Fulltext Elite | Baker Library
Health Business Fulltext Elite Journal articles on all non-clinical aspects of health care management. Read More Includes aspects of health View Details
- September 2014 (Revised May 2017)
- Case
Fresno's Social Impact Bond for Asthma
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Social Impact Bonds (SIBs) were quickly gaining popularity as an investment vehicle which joined together private investors and nonprofits to tackle social issues. Although numerous SIB projects and proposals had cropped up across the U.S. following the launch... View Details
Keywords: Social Enterprise; Health Care; Marketing; Bonds; Financing; Asthma; Air Pollution; Air Quality; Chronic Disease; Public Health; Health; Health Care and Treatment; Finance; Health Industry; Health Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "Fresno's Social Impact Bond for Asthma." Harvard Business School Case 515-028, September 2014. (Revised May 2017.)